Author:
Mishra Kaushick,Manna Asis,Roy Ram Mohan,Roy Yogiraj,Choudhury Koushik
Publisher
Jaypee Brothers Medical Publishing
Subject
Anesthesiology and Pain Medicine
Reference22 articles.
1. 1. Johns Hopkins University of Medicine COVID-19. COVID-19 Dashboard by the Center for Systems Science and. Engineering (CSSE) at Johns Hopkins University. 2020. Available from: https://coronavirus.jhu.edu/map.html. [Last accessed on 2021 Dec 25].
2. 2. Ahmed S, Karim MM, Ross AG, et al. A five–day course of Ivermectin for the treatment of COVID–19 may reduce the duration of illness. Int J Infect Dis 2021;103:214–216.
3. 3. Caly L, Druce JD, Catton MG, et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020;178:104787.
4. 4. Crump A, Ōmura S. Ivermectin, “wonder drug” from Japan: The human use perspective: Proc Jpn Acad Ser B Phys Biol Sci 2011;87:13–28.
5. 5. Kory P, Meduri GU, Varon J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. Am J Ther 2021;28:e299–318.